These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 34022901)

  • 21. Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique.
    Arnaldo P; Rovira-Vallbona E; Langa JS; Salvador C; Guetens P; Chiheb D; Xavier B; Kestens L; Enosse SM; Rosanas-Urgell A
    Malar J; 2018 Mar; 17(1):109. PubMed ID: 29530044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
    Mchwampaka WM; Tarimo D; Chacky F; Mohamed A; Kishimba R; Samwel A
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):440. PubMed ID: 31775686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja, Uganda.
    Sangaré LR; Stergachis A; Brentlinger PE; Richardson BA; Staedke SG; Kiwuwa MS; Weiss NS
    PLoS One; 2010 Nov; 5(11):e15066. PubMed ID: 21124732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.
    Anchang-Kimbi JK; Kalaji LN; Mbacham HF; Wepnje GB; Apinjoh TO; Ngole Sumbele IU; Dionne-Odom J; Tita ATN; Achidi EA
    Malar J; 2020 Mar; 19(1):100. PubMed ID: 32122339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlates of uptake of optimal doses of sulfadoxine-pyrimethamine for prevention of malaria during pregnancy in East-Central Uganda.
    Martin MK; Venantius KB; Patricia N; Bernard K; Keith B; Allen K; Godfrey A; Rogers T; Damazo KT; Dathan BM
    Malar J; 2020 Apr; 19(1):153. PubMed ID: 32295601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors Associated with Intermittent Preventive Treatment of Malaria During Pregnancy in Mali.
    Diarra SS; Konaté D; Diawara SI; Tall M; Diakité M; Doumbia S
    J Parasitol; 2019 Apr; 105(2):299-302. PubMed ID: 30969162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scaling-up the use of sulfadoxine-pyrimethamine for the preventive treatment of malaria in pregnancy: results and lessons on scalability, costs and programme impact from three local government areas in Sokoto State, Nigeria.
    Orobaton N; Austin AM; Abegunde D; Ibrahim M; Mohammed Z; Abdul-Azeez J; Ganiyu H; Nanbol Z; Fapohunda B; Beal K
    Malar J; 2016 Nov; 15(1):533. PubMed ID: 27814763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late ANC initiation and factors associated with sub-optimal uptake of sulphadoxine-pyrimethamine in pregnancy: a preliminary study in Cape Coast Metropolis, Ghana.
    Amoako BK; Anto F
    BMC Pregnancy Childbirth; 2021 Feb; 21(1):105. PubMed ID: 33530957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The readiness of malaria services and uptake of intermittent preventive treatment in pregnancy in six sub-Saharan countries.
    Xu X; Liang D; Zhao J; Mpembeni R; Olenja J; Yam EL; Huang J
    J Glob Health; 2024 Jun; 14():04112. PubMed ID: 38939971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.
    Orish VN; Onyeabor OS; Boampong JN; Afoakwah R; Nwaefuna E; Acquah S; Sanyaolu AO; Iriemenam NC
    Afr Health Sci; 2015 Dec; 15(4):1087-96. PubMed ID: 26958008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
    Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR
    Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Kenya.
    Hill J; Dellicour S; Bruce J; Ouma P; Smedley J; Otieno P; Ombock M; Kariuki S; Desai M; Hamel MJ; ter Kuile FO; Webster J
    PLoS One; 2013; 8(6):e64913. PubMed ID: 23798997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
    Walker PG; Floyd J; Ter Kuile F; Cairns M
    PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent use of sulphadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic.
    Odongo CO; Bisaso RK; Byamugisha J; Obua C
    Malar J; 2014 Oct; 13():399. PubMed ID: 25306431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermittent preventive treatment of malaria during pregnancy: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District, North-Eastern Tanzania.
    Mubyazi G; Bloch P; Kamugisha M; Kitua A; Ijumba J
    Malar J; 2005 Jul; 4():31. PubMed ID: 16033639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of group versus individual antenatal care on uptake of intermittent prophylactic treatment of malaria in pregnancy and related malaria outcomes in Nigeria and Kenya: analysis of data from a pragmatic cluster randomized trial.
    Noguchi L; Grenier L; Kabue M; Ugwa E; Oyetunji J; Suhowatsky S; Onguti B; Orji B; Whiting-Collins L; Adetiloye O
    Malar J; 2020 Jan; 19(1):51. PubMed ID: 31996209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective evaluation of referral by community health workers on the uptake of intermittent preventive treatment of Malaria in pregnancy in Ohaukwu, Ebonyi State, Nigeria.
    Orji BC; Bryce E; Odio B; Onuoha HE; Njoku E; Anoke C; Ugwa E; Enne J; Oniyire A; Otolorin E; Afolabi K; Ogbulafor NC; Oliveras E
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):599. PubMed ID: 35896992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of timely uptake of ITN and SP (IPT) and pregnancy time protected against malaria in Bukoba, Tanzania.
    Protas J; Tarimo D; Moshiro C
    BMC Res Notes; 2016 Jun; 9():318. PubMed ID: 27328717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial distribution and determinants of intermittent preventive treatment for malaria during pregnancy: a secondary data analysis of the 2019 Ghana malaria indicators survey.
    Ndayishimiye JC; Teg-Nefaah Tabong P
    BMC Pregnancy Childbirth; 2024 May; 24(1):379. PubMed ID: 38769513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine and parasite resistance: cross-sectional surveys from antenatal care visit and delivery in rural Ghana.
    Mama A; Ahiabor C; Tornyigah B; Frempong NA; Kusi KA; Adu B; Courtin D; Houzé S; Deloron P; Ofori MF; Anang AK; Ariey F; Ndam NT
    Malar J; 2022 Mar; 21(1):107. PubMed ID: 35346205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.